PLTR Stock Today: March 17 Anthropic-Pentagon Clash Clouds Claude Link
Artificial intelligence news today centres on Defence policy shifts. Reports suggest the Pentagon may curb Anthropic tools while Anthropic’s Claude still connects through Palantir’s AIP. For UK investors in PLTR, this mix raises procurement and integration risks. Palantir’s model-agnostic design helps, yet rule changes can slow deals. We review the links to Claude, the AI safety hiring push, and how potential US restrictions could ripple across NATO buyers. We also cover key valuation markers, technical levels, and what to watch into the next earnings date.
Anthropic–Pentagon clash: why it matters for Palantir
Palantir’s Artificial Intelligence Platform lets customers route tasks across multiple large language models, including Claude. If US defence users restrict Anthropic access, teams may need to reconfigure workflows and retrain agents. The good news is AIP’s model-agnostic setup limits vendor lock-in. The risk is short-term friction that can slow pilots, extend validations, and push sign-offs into later quarters.
A tightening stance on AI safety is already visible. Anthropic is recruiting a weapons-misuse specialist to harden safeguards, according to the BBC source. For Palantir, any Claude curbs could add supply-chain checks and new attestations. That may delay US awards and, by extension, influence UK and NATO procurement standards, given close alignment on security and audit trails.
AI safety hiring and guardrails: the sector signal
Artificial intelligence news also highlights wider hiring across labs. OpenAI and Anthropic are adding experts in chemical and explosive risks to reduce dual-use harms, as reported by the Indian Express source. We read this as a sign that defence and critical-infra buyers will demand stronger proof of safety, provenance, and model isolation in 2026 frameworks.
For Palantir customers, stricter guardrails likely mean clearer model catalogs, red-team evidence, and kill-switch designs. That supports long-term adoption but can extend near-term timelines. We expect more vendor questionnaires, sandbox pilots, and binding service levels. Firms that show auditable controls and quick model swaps should win budget, even if integration sprints become more phased.
PLTR fundamentals and valuation snapshot
PLTR recently traded at $155.08, up 1.55% in the latest session, with a 52-week range of $66.12 to $207.52. FY2024 revenue rose about 28.8% year over year, with strong gross margins. TTM EPS is 0.63 and ROE is 25.7%. Balance sheet quality looks solid with a 7.1 current ratio and low debt. Next earnings are scheduled for 4 May 2026 at 20:00 UTC.
Valuation is rich: PE 246.2, price-to-sales 78.4, and price-to-free-cash-flow 167.0. That leaves limited room for execution slips or elongated deal cycles tied to policy reviews. Analysts show a mixed stance with 17 Buy, 14 Hold, and 5 Sell ratings. Our Stock Grade reads B+ with a buy suggestion, while a separate company rating today is B, Neutral.
Technical setup and levels UK traders watch
Momentum is constructive but not stretched. RSI sits at 57.5 and MACD is positive. Money Flow Index is 75.8, near overbought, so demand may cool on spikes. Price trades around the 50‑day average of $153.35, below the 200‑day at $162.95. Recent intraday range is $152.12 to $156.75. ATR of 6.55 signals moderate daily volatility.
We would respect the 50‑day average near $153 as first support and the upper Bollinger Band around $163 as resistance. A daily close above $163 could invite momentum flows, while a break below $152 risks a deeper pullback. Position sizing should reflect policy headline risk. Consider staged entries and stop-losses adjusted to ATR.
Final Thoughts
Here is our bottom line for UK investors. Artificial intelligence news points to tighter defence AI rules, and the Anthropic–Pentagon dispute could slow model approvals. Palantir’s AIP can switch providers, which limits structural risk, but integration and procurement friction may weigh on near-term bookings. The stock’s premium multiples mean execution must stay strong. We would track three items: 1) any formal US guidance on Claude use, 2) disclosures on federal and NATO pipeline quality at the 4 May earnings call, and 3) technical behavior around $153 support and $163 resistance. Keep sizes modest, expect headline-driven swings, and factor USD exposure into return planning.
FAQs
How could the Anthropic–Pentagon dispute affect PLTR contracts?
If defence users restrict Claude, some Palantir projects may need model swaps, extra testing, and new attestations. AIP’s model-agnostic design reduces lock‑in, but procurement checks can slow approvals. We see a timing risk to federal and allied deals rather than a long-term platform risk, if customers accept audited alternatives.
Does Palantir rely on Claude for AIP?
Palantir AIP can route tasks to multiple models, including Claude, open-source, and commercial LLMs. That flexibility helps customers meet policy or security rules. If one model is limited, teams can reconfigure workflows to approved options. The trade-off is added validation work that may extend timelines for sensitive use cases.
Is PLTR stock expensive compared with peers?
By classic metrics, yes. PLTR trades around 246 times TTM earnings and about 78 times TTM sales. Free cash flow and growth are strong, but expectations are high. Any slowdown in federal bookings or delays from safety reviews could compress multiples. Position sizing and disciplined entries matter at these levels.
What should UK investors watch next from artificial intelligence news?
Focus on formal defence guidance about model selection, vendor safety attestations, and supply‑chain rules. For PLTR, watch the 4 May 2026 earnings call for updates on US federal and NATO pipelines. Also monitor technical levels near $153 and $163, since policy headlines can quickly shift momentum and trading ranges.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)